Park S, Yi E, Jeon J, Oh J, Xu Z, Park S
Int J Mol Sci. 2025; 26(1.
PMID: 39796009
PMC: 11720714.
DOI: 10.3390/ijms26010149.
Abebaw D, Akelew Y, Adugna A, Teffera Z, Tegegne B, Fenta A
Front Immunol. 2024; 15:1499929.
PMID: 39624102
PMC: 11609219.
DOI: 10.3389/fimmu.2024.1499929.
Mao X, Shi M, Zhang B, Fu R, Cai M, Yu S
Immunol Res. 2024; 72(5):1120-1135.
PMID: 39009881
DOI: 10.1007/s12026-024-09513-5.
Dileepan K, Raveendran V, Sharma R, Abraham H, Barua R, Singh V
Front Med (Lausanne). 2023; 10:1213320.
PMID: 37663654
PMC: 10470157.
DOI: 10.3389/fmed.2023.1213320.
Gutowski L, Kanikowski S, Formanowicz D
Life (Basel). 2023; 13(8).
PMID: 37629547
PMC: 10455104.
DOI: 10.3390/life13081690.
Association of mast-cell-related conditions with hypermobile syndromes: a review of the literature.
Monaco A, Choi D, Uzun S, Maitland A, Riley B
Immunol Res. 2022; 70(4):419-431.
PMID: 35449490
PMC: 9022617.
DOI: 10.1007/s12026-022-09280-1.
Mannan-Binding Lectin Deficiency Limits Inflammation-induced Myeloid-Derived Suppressor Cells Expansion via Modulating Tumor Necrosis Factor Alpha-triggered Apoptosis.
Dong L, Jiang H, Chen K, Xie J, An Q, Deng F
Int J Biol Sci. 2022; 18(4):1580-1593.
PMID: 35280697
PMC: 8898356.
DOI: 10.7150/ijbs.68865.
Identification and Validation of ATF3 Serving as a Potential Biomarker and Correlating With Pharmacotherapy Response and Immune Infiltration Characteristics in Rheumatoid Arthritis.
Hu H, Zhang F, Li L, Liu J, Ao Q, Li P
Front Mol Biosci. 2021; 8:761841.
PMID: 34966780
PMC: 8710747.
DOI: 10.3389/fmolb.2021.761841.
Intra-Articular Drug Delivery for Osteoarthritis Treatment.
Cao Y, Ma Y, Tao Y, Lin W, Wang P
Pharmaceutics. 2021; 13(12).
PMID: 34959445
PMC: 8703898.
DOI: 10.3390/pharmaceutics13122166.
Mast Cells as Important Regulators in Autoimmunity and Cancer Development.
Noto C, Hoft S, DiPaolo R
Front Cell Dev Biol. 2021; 9:752350.
PMID: 34712668
PMC: 8546116.
DOI: 10.3389/fcell.2021.752350.
Identifying Immune Cell Infiltration and Effective Diagnostic Biomarkers in Rheumatoid Arthritis by Bioinformatics Analysis.
Zhou S, Lu H, Xiong M
Front Immunol. 2021; 12:726747.
PMID: 34484236
PMC: 8411707.
DOI: 10.3389/fimmu.2021.726747.
Mast cells: Therapeutic targets for COVID-19 and beyond.
Lam H, Tergaonkar V, Kumar A, Ahn K
IUBMB Life. 2021; 73(11):1278-1292.
PMID: 34467628
PMC: 8652840.
DOI: 10.1002/iub.2552.
Biosynthesis of gold nanoparticles for the treatment of osteoarthritis alone or in combination with Diacerein in a rat model.
Abdel-Aziz M, Ahmed H, El-Nekeety A, Sharaf H, Abdel-Aziem S, Abdel-Wahhab M
Inflammopharmacology. 2021; 29(3):705-719.
PMID: 34117571
DOI: 10.1007/s10787-021-00833-8.
The pLysRS-ApA Pathway in Mast Cells Regulates the Switch from Host Defense to a Pathological State.
Govindaraj S, Paruchuru L, Razin E
Int J Mol Sci. 2021; 22(11).
PMID: 34070694
PMC: 8198065.
DOI: 10.3390/ijms22115620.
The Immunomodulatory and Anti-Inflammatory Effect of Curcumin on Immune Cell Populations, Cytokines, and In Vivo Models of Rheumatoid Arthritis.
Makuch S, Wiecek K, Wozniak M
Pharmaceuticals (Basel). 2021; 14(4).
PMID: 33915757
PMC: 8065689.
DOI: 10.3390/ph14040309.
Neuroimmune connections between corticotropin-releasing hormone and mast cells: novel strategies for the treatment of neurodegenerative diseases.
Bhuiyan P, Wang Y, Sha H, Dong H, Qian Y
Neural Regen Res. 2021; 16(11):2184-2197.
PMID: 33818491
PMC: 8354134.
DOI: 10.4103/1673-5374.310608.